NCT01282424 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 125
- units
- Participants
- groups
- description
- Idelalisib 150 mg tablet administered orally twice daily until tumor progression or development of unacceptable toxicity.
- id
- BG000
- title
- Idelalisib
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.4
- value
- 62
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 45
- title
- Female
- measurements
- group Id
- BG000
- value
- 80
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 110
- title
- White/Caucasian
- measurements
- group Id
- BG000
- value
- 2
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 3
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 8
- title
- Other
- measurements
- group Id
- BG000
- value
- 1
- title
- Missing
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 117
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 2
- title
- Missing
- title
- Ethnicity
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 10
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 83
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 10
- title
- Germany
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- United Kingdom
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Italy
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Score = 60
- measurements
- group Id
- BG000
- value
- 6
- title
- Score = 70
- measurements
- group Id
- BG000
- value
- 27
- title
- Score = 80
- measurements
- group Id
- BG000
- value
- 44
- title
- Score = 90
- measurements
- group Id
- BG000
- value
- 46
- title
- Score = 100
- description
- Karnofsky performance status classified participants according to their functional impairment. Scores ranged from 0-100, the lower the score, the worse the survival for most serious illnesses.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Karnofsky Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 72
- title
- Folicular lymphoma
- measurements
- group Id
- BG000
- value
- 28
- title
- Small lymphocytic lymphoma
- measurements
- group Id
- BG000
- value
- 10
- title
- LPL/WM
- measurements
- group Id
- BG000
- value
- 15
- title
- Marginal zone lymphoma
- description
- LPL/WM: Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Baseline Disease History
- unit Of Measure
- Participants
- population Description
- ITT analysis set included enrolled participants who received at least one dose of study drug.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 125
- units
- Participants
- groups
- description
- Idelalisib 150 mg tablet administered orally twice daily until tumor progression or development of unacceptable toxicity.
- id
- BG000
- title
- Idelalisib
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.4
- value
- 62
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 45
- title
- Female
- measurements
- group Id
- BG000
- value
- 80
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 110
- title
- White/Caucasian
- measurements
- group Id
- BG000
- value
- 2
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 3
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 8
- title
- Other
- measurements
- group Id
- BG000
- value
- 1
- title
- Missing
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 117
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 2
- title
- Missing
- title
- Ethnicity
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 10
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 83
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 10
- title
- Germany
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- United Kingdom
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Italy
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Score = 60
- measurements
- group Id
- BG000
- value
- 6
- title
- Score = 70
- measurements
- group Id
- BG000
- value
- 27
- title
- Score = 80
- measurements
- group Id
- BG000
- value
- 44
- title
- Score = 90
- measurements
- group Id
- BG000
- value
- 46
- title
- Score = 100
- description
- Karnofsky performance status classified participants according to their functional impairment. Scores ranged from 0-100, the lower the score, the worse the survival for most serious illnesses.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Karnofsky Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 72
- title
- Folicular lymphoma
- measurements
- group Id
- BG000
- value
- 28
- title
- Small lymphocytic lymphoma
- measurements
- group Id
- BG000
- value
- 10
- title
- LPL/WM
- measurements
- group Id
- BG000
- value
- 15
- title
- Marginal zone lymphoma
- description
- LPL/WM: Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Baseline Disease History
- unit Of Measure
- Participants
- population Description
- ITT analysis set included enrolled participants who received at least one dose of study drug.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle